FIG. 3.

(A, B) To determine the functional status of patients, NYHA classification and BNP levels were measured at 3, 6, and 12 months after procedure in both groups. There were no significant differences of baseline NYHA classification and BNP level in both groups. At 3, 6, and 12 months after cell therapy, there was a significant decrease of NYHA classification and BNP level compared with baseline. In the control group without cell therapy, there were no significant changes in NYHA classification and BNP level at 3, 6, and 12 months after coronary angiography compared with baseline. Moreover, significant differences in NYHA classification and BNP level were observed at 3, 6, and 12 months after procedure between both groups. NYHA, New York Heart Association; BNP, brain natriuretic peptide. Color images available online at www.liebertonline.com/scd